Cerebral Microbleeds in Ischemic Stroke Patients on Warfarin Treatment
Key points
- Cerebral microbleeds (CMBs) are known to be indicative of bleeding prone microangiopathy.
- From the Departments of Neurology (D.N.O., G.K., H.F.) and Radiology (E.U.), Sisli Etfal Education and Research Hospital, Istanbul, Turkey.
- Methods— A total of 141 ischemic stroke patients on warfarin therapy were enrolled in this study.
- Results— CMBs on gradient-echo MRI (GE-MRI) were found in 31 patients (22%) and 17 controls (16%) and there was not a significant difference between 2 groups (P=0.25).
Cerebral microbleeds (CMBs) are known to be indicative of bleeding prone microangiopathy. Little is known about its significance in anticoagulated patients. We aimed to determine the frequency of CMBs in ischemic stroke patients on warfarin treatment.
Methods— A total of 141 ischemic stroke patients on warfarin therapy were enrolled in this study. One hundred five patients with similar demographic features who do not use warfarin were chosen as controls. We compared vascular risk factors and radiological findings including CMBs and leukoaraiosis between the groups.
Results— CMBs on gradient-echo MRI (GE-MRI) were found in 31 patients (22%) and 17 controls (16%) and there was not a significant difference between 2 groups (P=0.25). Study patients with CMBs were older than patients without CMBs (P=0.04) and frequency of leukoaraiosis was significantly higher (P=0.008). Mean duration of warfarin treatment was not different between the patients with and without CMBs (P=0.83).
Conclusion— Although patients with CMBs were older and had more leukoaraiosis the impact of warfarin treatment on CMBs is still controversial.
Key Words: cerebral microbleeds • warfarin • ischemic stroke • magnetic resonance imaging
Dilek Necioglu Orken, MD; Gulay Kenangil, MD; Ender Uysal, MD Hulki Forta, MD
From the Departments of Neurology (D.N.O., G.K., H.F.) and Radiology (E.U.), Sisli Etfal Education and Research Hospital, Istanbul, Turkey.
Correspondence to Dilek Necioglu Orken, Emirhan cd. No:41/12 Dikilitas 34349 Istanbul, Turkey. E-mail dilek.necioglu@gmail.com
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Brain & Nerves →Study evaluates 'normal range' systolic bp levels after ischemic stroke and risk of recurrent stroke
Among patients who experienced an ischemic stroke, systolic blood pressure levels of less than 120 mm Hg, or higher than 140 mm Hg, were associated with an increased risk of subsequent stroke, according to a study…
16 November 2011
